Study Stopped
COVID 19
Virtual Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Vision loss is common among older adults and leads to an increased risk for depression and difficulties in daily tasks, thus requiring dependence on caregivers. This study will assess the feasibility of providing two virtual interventions, Sahaj Samadhi Meditation (SSM) and Health Enhancement Program (HEP), to supplement care of patients with irreversible age-related vision loss (IARVL) and their caregivers, with the goal of enhancing mental health and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2020
CompletedFirst Posted
Study publicly available on registry
October 12, 2020
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2022
CompletedApril 18, 2022
April 1, 2022
8 days
September 21, 2020
April 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Number of Potential Participants Approached Per Month
The number of potential participants approached per month will be calculated as a feasibility measure.
1 year
Number of Participants who are Successfully Screened
The number of participants who are successfully screened will be calculated as a feasibility measure.
1 year
Proportion of Successfully Screened in Participants who Enroll
The proportion of successfully screened in participants who enroll in the study will be calculated as a feasibility measure.
1 year
Rate of Retention
The rate of retention of participants in the study will be calculated as a feasibility measure.
1 year
Rate of Adherence to Study Protocol
At the end of the study any deviations from the protocol will be examined to determine the rate of adherence to the study protocol. This information will be calculated as a feasibility measure.
1 year
Proportion of Planned Ratings that are Completed
The proportion of completed planned ratings will be calculated as a feasibility measure.
1 year
Intervention Cost Per Case
The cost per participant of attending the SSM program will be calculated as a feasibility measure.
1 year
Percentage of Time Trade-Off (TTO) Questionnaires Completed
The percentage of TTO questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Visual Function Index (VF-14) Questionnaires Completed
The percentage of VF-14 questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Center for Epidemiologic Studies - Depression (CES-D) Questionnaires Completed
The percentage of CES-D questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Hospital Anxiety and Depression Scale - Anxiety (HADS-A) Questionnaires Completed
The percentage of HADS-A questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Pittsburgh Sleep Quality Index (PSQI) Questionnaires Completed
The percentage of PSQI questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Community Integration Questionnaire (CIQ) Questionnaires Completed
The percentage of CIQ questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Connor-Davidson Resilience Scale (CD-RISC) Questionnaires Completed
The percentage of CD-RISC questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Percentage of Zarit Burden Interview (ZBI) Questionnaires Completed
The percentage of ZBI questionnaires completed by each participant will be examined at the end of the study to assess the completeness of the data as a feasibility measure.
1 year
Secondary Outcomes (8)
Change in Health-Related Quality of Life Score
Weeks 0 and 12
Change in Vision-Related Quality of Life Score
Weeks 0 and 12
Change in Depressive Symptoms
Weeks 0 and 12
Change in Anxiety Symptoms
Weeks 0 and 12
Change in Sleep Quality: Pittsburgh Sleep Quality Index (PSQI)
Weeks 0 and 12
- +3 more secondary outcomes
Study Arms (3)
Sahaj Samadhi Meditation
EXPERIMENTALParticipants randomized to the Sahaj Samadhi Meditation (SSM) arm will undergo SSM training in groups of 10. SSM will be delivered virtually using the Cisco WebEx platform by trained, certified non-clinician teachers. Participants will be trained for 4 consecutive days (2 hours/day) in the first week, followed by 1-hour weekly reinforcement sessions for 11 weeks. Participants will also be encouraged to practice twice daily at home for 20 minutes per session. They will be given a daily practice log on which they check off a box indicating if they have done their home practice.
Health Enhancement Program
ACTIVE COMPARATORParticipants randomized to the Health Enhancement Program (HEP) arm will undergo HEP training in groups of 10. HEP will be delivered virtually using the Cisco WebEx platform by trained non-clinician teachers. Participants will be trained for 4 consecutive days (2 hours/day) in the first week, followed by 1-hour weekly reinforcement sessions for 11 weeks. Participants will also be encouraged to practice twice daily at home for 20 minutes per session. They will be given a daily practice log on which they check off a box indicating if they have done their home practice.
Treatment as Usual
NO INTERVENTIONParticipants randomized to the Treatment as Usual (TAU) arm will continue to receive their treatment as usual. The usual standard of care for irreversible age-related vision patients includes no active treatment since eye surgeons have done all that could possibly be done to restore vision.
Interventions
Sahaj Samadhi Meditation (SSM) is a form of automatic self-transcending meditation that involves relaxed attention to a precise sound (mantra), to allow stress reduction and deep relaxation. This technique is easy to learn and offers the support of a group and facilitator.
The Health Enhancement Program (HEP) is a standardized program used to teach participants about health promotion, including the benefits of a lifestyle of healthy diet, music, recreation, and exercise. In HEP, participants get the support of a group and facilitator, and talk through and try to implement positive health-enhancing life changes.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with irreversible age-related vision loss (IARVL) by an experienced ophthalmologist and/or their caregivers.
- IARVL patients between the age range of 60 to 85 years, while caregivers between the age range of 18 to 85 years.
- Be able to provide valid informed consent to participate in the research study.
- Being able to speak as well as understand English without the requirement for interpretation or other communication assistance.
- Having no significant self-reported or a physician-diagnosed mental health disorder other than depressive and/or anxiety symptoms.
- Should reach a minimal threshold of depressive and/or anxiety symptoms as confirmed by either a minimum of Centre for Epidemiologic Studies - Depression (CES-D) 20-item scale score of 16 OR a minimum of 8 on the Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-A).
- Have sufficient hearing to be able to follow verbal instructions
- Have the ability to sit independently without physical discomfort for 30 minutes.
- Willing and able to attend virtual intervention via Cisco WebEx software, the four initial training sessions of SSM or HEP and at least 6 out of 11 weekly follow-up sessions.
- Willing to dedicate 20 minutes twice per day six days per week to their assigned home practice.
You may not qualify if:
- Inability to provide a valid informed consent.
- Having an underlying major neurocognitive disorder as suggested by a Montreal Cognitive Assessment (MoCA) score \< 21.
- Having significant suicidal ideation as per self-report (CES-D = 3 on item question 14 and/or 15).
- Having severe depression as confirmed by a CES-D ≥ 24.
- Participating in other similar studies.
- Having a lifetime diagnosis of self-reported other serious mental disorders, including bipolar I or II disorder, primary psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder).
- Self-reported substance abuse or dependence within the past 3 months.
- Having an acutely unstable medical illnesses, including delirium or acute cerebrovascular or cardiovascular events within the last 6 months.
- Having a terminal medical diagnosis with prognosis of less than 12 months.
- Having any planned changes to mood-altering medications at the time of enrollment for the next 12 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Akshya Vasudev, MD
London Health Sciences Centre
- PRINCIPAL INVESTIGATOR
Cindy Hutnik, MD, PhD
St. Joseph's Healthcare London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants will be blinded to the treatment hypothesis, while investigators and treating clinicians will be additionally blinded to the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Geriatric Psychiatrist
Study Record Dates
First Submitted
September 21, 2020
First Posted
October 12, 2020
Study Start
April 1, 2022
Primary Completion
April 9, 2022
Study Completion
April 9, 2022
Last Updated
April 18, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share